https://angleplc.com/ | Texto ancla | Skip to content |
https://angleplc.com/ | | IMG-ALT Angle logo |
https://angleplc.com/about-us/ | | About us |
https://angleplc.com/about-us/ | | Discover ANGLE |
/about-us/our-team/ | | Our team |
/about-us/careers/ | | Careers |
/about-us/events/ | | Events |
https://angleplc.com/news/ | | News |
/about-us/corporate-social-res... | | Corporate social responsibility |
/parsortix-technology/ | | Technology |
/parsortix-technology/ | | Parsortix® technology |
/the-parsortix-pc1-system/ | | Parsortix PC1 system – clinical |
/parsortix-pr1/ | | Parsortix PR1 system – research |
/product-solutions/ | | Product solutions |
/product-solutions/ | | Discover all Product solutions |
/the-parsortix-pc1-system/ | Texto duplicado | Parsortix PC1 system – clinical |
/parsortix-pr1/ | Texto duplicado | Parsortix PR1 system – research |
/portrait-plus/ | | Portrait+ CTC Staining Kit |
/laboratory-services/ | | Laboratory services |
/laboratory-services/ | | Discover all Laboratory services |
/laboratory-services/enumeration/ | | Enumeration |
/laboratory-services/portrait-... | | Portrait®Flex |
/laboratory-services/dna-damag... | | DNA damage response (DDR) |
/laboratory-services/portrait-... | | Portrait®PD-L1 |
/laboratory-services/custom-ct... | | Custom CTC assays |
/product-information/ | | Resources |
/translational-research/ | | Translational research |
/product-information/ | | Product information |
/publications/ | | Publications |
https://angleplc.com/ivd-ifu/ | | Instructions for Use documents |
https://angleplc.com/contact-us/ | | Contact us |
/information-for-investors-ang... | | Investors |
/information-for-investors-ang... | Texto duplicado | Investors |
/information-for-investors-ang... | | Business strategy |
/information-for-investors-ang... | | Market size |
/information-for-investors-ang... | | Regulatory news |
/information-for-investors-ang... | | Share price |
/information-for-investors-ang... | | Financial reports |
/investor-relations/financial-... | Texto ancla | Financial Calendar |
/information-for-investors-ang... | | Corporate responsibility report |
/information-for-investors-ang... | | Glossary |
/information-for-investors-ang... | | AIM Rule 26 |
/information-for-investors-ang... | | Corporate governance |
/information-for-investors-ang... | | Significant shareholders |
/information-for-investors-ang... | | ADR |
/information-for-investors-ang... | | Advisors |
/information-for-investors-ang... | | Corporate presentations |
/information-for-investors-ang... | | ANGLE in the media |
/information-for-investors-ang... | | Analyst research |
/wp-content/uploads/2024/06/AN... | | Open PDF |
https://angleplc.com/about-us/ | Texto duplicado | Discover ANGLE |
/about-us/our-team/ | Texto duplicado | Our team |
/about-us/careers/ | Texto duplicado | Careers |
/about-us/events/ | Texto duplicado | Events |
/about-us/corporate-social-res... | Texto duplicado | Corporate social responsibility |
/parsortix-technology/ | | Parsortix®technology |
/the-parsortix-pc1-system/ | Texto duplicado | Parsortix PC1 system – clinical |
/parsortix-pr1/ | Texto duplicado | Parsortix PR1 system – research |
/product-solutions/ | Texto duplicado | Discover all Product solutions |
/portrait-plus/ | | Portrait+ CTC staining kit |
/the-parsortix-pc1-system/ | Texto duplicado | Parsortix PC1 system – clinical |
/parsortix-pr1/ | Texto duplicado | Parsortix PR1 system – research |
/laboratory-services/ | Texto duplicado | Discover all Laboratory services |
/laboratory-services/enumeration/ | | CTC enumeration |
/laboratory-services/portrait-... | Texto duplicado | Portrait®Flex |
/laboratory-services/dna-damag... | Texto duplicado | DNA damage response (DDR) |
/laboratory-services/portrait-... | Texto duplicado | Portrait®PD-L1 |
/laboratory-services/custom-ct... | Texto duplicado | Custom CTC assays |
/translational-research/ | Texto duplicado | Translational research |
/product-information/ | Texto duplicado | Product information |
/publications/ | Texto duplicado | Publications |
https://angleplc.com/ivd-ifu/ | Texto duplicado | Instructions for Use documents |
https://angleplc.com/contact-us/ | Texto duplicado | Contact us |
/information-for-investors-ang... | Texto duplicado | Investors |
/information-for-investors-ang... | Texto duplicado | Business strategy |
/information-for-investors-ang... | Texto duplicado | Market size |
/information-for-investors-ang... | Texto duplicado | Regulatory news |
/information-for-investors-ang... | Texto duplicado | Share price |
/information-for-investors-ang... | Texto duplicado | Financial reports |
/information-for-investors-ang... | Texto duplicado | Corporate responsibility report |
/information-for-investors-ang... | Texto duplicado | Glossary |
/information-for-investors-ang... | | Email alerts |
/information-for-investors-ang... | | AIM 26 |
/information-for-investors-ang... | Texto duplicado | Corporate governance |
/information-for-investors-ang... | Texto duplicado | Significant shareholders |
/information-for-investors-ang... | Texto duplicado | ADR |
/information-for-investors-ang... | Texto duplicado | Advisors |
/information-for-investors-ang... | Texto duplicado | Corporate presentations |
/information-for-investors-ang... | Texto duplicado | ANGLE in the media |
/information-for-investors-ang... | Texto duplicado | Analyst research |
/about-us/events/ | | Discover more |
/parsortix-technology/ | Texto duplicado | Discover more |
/parsortix-technology/the-pars... | Texto duplicado | Discover more |
/onc-adapt-laboratories/ | Texto duplicado | Discover more |
/parsortix-technology/the-pars... | Texto duplicado | Discover more |
/onc-adapt-laboratories/ | Texto duplicado | Discover more |
/publications/ | Texto duplicado | Discover more |
/wp-content/uploads/2024/06/PT... | Nueva ventana Texto duplicado | Open PDF |
/wp-content/uploads/2024/06/PT... | Nueva ventana Texto duplicado | Open PDF |
/wp-content/uploads/2024/05/PT... | Nueva ventana Texto duplicado | Open PDF |
/wp-content/uploads/2024/05/In... | Nueva ventana Texto duplicado | Open PDF |
https://angleplc.com/contact-us/ | Texto duplicado | Contact us |
https://angleplc.com/about-us/ | Texto duplicado | About us |
/about-us/our-team/ | Texto duplicado | Our team |
/about-us/careers/ | Texto duplicado | Careers |
/about-us/events/ | Texto duplicado | Events |
https://angleplc.com/news/ | Texto duplicado | News |
/about-us/corporate-social-res... | Texto duplicado | Corporate social responsibility |
/parsortix-technology/ | Texto duplicado | Technology |
/parsortix-technology/ | Texto duplicado | Parsortix®technology |
/the-parsortix-pc1-system/ | Texto duplicado | Parsortix PC1 system – clinical |
/parsortix-pr1/ | Texto duplicado | Parsortix PR1 system – research |
/product-solutions/ | Texto duplicado | Product solutions |
/the-parsortix-pc1-system/ | Texto duplicado | Parsortix PC1 system – clinical |
/parsortix-pr1/ | Texto duplicado | Parsortix PR1 system – research |
/portrait-plus/ | Texto duplicado | Portrait+ CTC staining kit |
/laboratory-services/ | Texto duplicado | Laboratory services |
/laboratory-services/enumeration/ | Texto duplicado | CTC enumeration |
/laboratory-services/portrait-... | Texto duplicado | Portrait®Flex |
/laboratory-services/dna-damag... | Texto duplicado | DNA damage response (DDR) |
/laboratory-services/portrait-... | Texto duplicado | Portrait®PD-L1 |
/laboratory-services/custom-ct... | Texto duplicado | Custom CTC assays |
/translational-research/ | Texto duplicado | Translational research |
/product-information/ | Texto duplicado | Product information |
/publications/ | Texto duplicado | Publications |
https://angleplc.com/ivd-ifu/ | Texto duplicado | Instructions for Use documents |
/information-for-investors-ang... | Texto duplicado | Investors |
/information-for-investors-ang... | Texto duplicado | Business strategy |
/information-for-investors-ang... | Texto duplicado | Market size |
/information-for-investors-ang... | Texto duplicado | Regulatory news |
/information-for-investors-ang... | Texto duplicado | Share price |
/information-for-investors-ang... | Texto duplicado | Corporate presentations |
/information-for-investors-ang... | Texto duplicado | Financial reports |
/information-for-investors-ang... | Texto duplicado | Corporate responsibility report |
/investor-relations/aim-rule-26/ | Texto duplicado | AIM Rule 26 |
/information-for-investors-ang... | Texto duplicado | Corporate governance |
/information-for-investors-ang... | Texto duplicado | ANGLE in the media |
https://angleplc.com/contact-us/ | Texto duplicado | Contact us |
/iso-certificates/ | | ISO certificates |
https://angleplc.com/about-us/ | Texto duplicado | About us |
/about-us/our-team/ | Texto duplicado | Our team |
/about-us/careers/ | Texto duplicado | Careers |
/about-us/events/ | Texto duplicado | Events |
https://angleplc.com/news/ | Texto duplicado | News |
/about-us/corporate-social-res... | Texto duplicado | Corporate social responsibility |
/parsortix-technology/ | Texto duplicado | Technology |
/parsortix-technology/ | Texto duplicado | Parsortix®technology |
/the-parsortix-pc1-system/ | Texto duplicado | Parsortix PC1 system – clinical |
/parsortix-pr1/ | Texto duplicado | Parsortix PR1 system – research |
/product-solutions/ | Texto duplicado | Product solutions |
/the-parsortix-pc1-system/ | Texto duplicado | Parsortix PC1 system – clinical |
/parsortix-pr1/ | Texto duplicado | Parsortix PR1 system – research |
/portrait-plus/ | Texto duplicado | Portrait+ CTC staining kit |
/laboratory-services/ | Texto duplicado | Laboratory services |
/laboratory-services/enumeration/ | Texto duplicado | CTC enumeration |
/laboratory-services/portrait-... | Texto duplicado | Portrait®Flex |
/laboratory-services/dna-damag... | Texto duplicado | DNA damage response (DDR) |
/laboratory-services/portrait-... | Texto duplicado | Portrait®PD-L1 |
/laboratory-services/custom-ct... | Texto duplicado | Custom CTC assays |
/translational-research/ | Texto duplicado | Translational research |
/product-information/ | Texto duplicado | Product information |
/publications/ | Texto duplicado | Publications |
https://angleplc.com/ivd-ifu/ | Texto duplicado | Instructions for Use documents |
/information-for-investors-ang... | Texto duplicado | Investors |
/information-for-investors-ang... | Texto duplicado | Business strategy |
/information-for-investors-ang... | Texto duplicado | Market size |
/information-for-investors-ang... | Texto duplicado | Regulatory news |
/information-for-investors-ang... | Texto duplicado | Share price |
/information-for-investors-ang... | Texto duplicado | Corporate presentations |
/information-for-investors-ang... | Texto duplicado | Financial reports |
/information-for-investors-ang... | Texto duplicado | Corporate responsibility report |
/investor-relations/aim-rule-26/ | Texto duplicado | AIM Rule 26 |
/information-for-investors-ang... | Texto duplicado | Corporate governance |
/information-for-investors-ang... | Texto duplicado | ANGLE in the media |
https://angleplc.com/contact-us/ | Texto duplicado | Contact us |
/iso-certificates/ | Texto duplicado | ISO certificates |
https://angleplc.com/ | | Sin texto |
https://www.google.com/maps/pl... | Nueva ventana Externo Subdominio | 2 Occam Court, Occam Road, Surrey Research Park, Guildford, GU2 7QB, UK |
https://www.google.com/maps/pl... | Nueva ventana Externo Subdominio | 5100 Campus Drive, Suite 120, Plymouth Meeting, PA 19462, USA |
https://www.google.com/maps/pl... | Nueva ventana Externo Subdominio | 10 Nugent Road, Surrey Research Park, Guildford, GU2 7AF, UK |
/privacy-policy/ | | Privacy policy |
/cookies-declaration/ | | Cookies declaration |
/terms-conditions/ | | Terms & conditions |
https://twitter.com/parsortix?... | Nueva ventana Externo | Sin texto |
https://www.linkedin.com/compa... | Nueva ventana Externo Subdominio | Sin texto |
(Deseable)